BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35313793)

  • 1. Effectiveness and immune responses of focused ultrasound ablation for cervical intraepithelial neoplasia.
    Zeng H; Liu M; Xiao L; Zhang X; Feng Q; Chang S
    Int J Hyperthermia; 2022; 39(1):539-546. PubMed ID: 35313793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
    Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
    J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.
    Chen W; Zhang Y; Zhao C; Shao S; Zhang Y; Li X; Bai X; Guo Q; Liu Q; Tang J; Zhang L
    Front Immunol; 2020; 11():612547. PubMed ID: 33552075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
    Yang W; Song Y; Lu YL; Sun JZ; Wang HW
    Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
    Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
    Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia.
    Visser J; van Baarle D; Hoogeboom BN; Reesink N; Klip H; Schuuring E; Nijhuis E; Pawlita M; Bungener L; de Vries-Idema J; Nijman H; Miedema F; Daemen T; van der Zee A
    Int J Cancer; 2006 May; 118(10):2529-37. PubMed ID: 16353143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.
    Kobayashi A; Greenblatt RM; Anastos K; Minkoff H; Massad LS; Young M; Levine AM; Darragh TM; Weinberg V; Smith-McCune KK
    Cancer Res; 2004 Sep; 64(18):6766-74. PubMed ID: 15374995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix.
    Sharma A; Rajappa M; Saxena A; Sharma M
    Int J Gynecol Cancer; 2007; 17(4):879-85. PubMed ID: 17343606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study.
    Sarkar AK; Tortolero-Luna G; Follen M; Sastry KJ
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S251-61. PubMed ID: 16188303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia.
    Iwata T; Fujii T; Morii K; Saito M; Sugiyama J; Nishio H; Morisada T; Tanaka K; Yaguchi T; Kawakami Y; Aoki D
    Int J Clin Oncol; 2015 Feb; 20(1):126-33. PubMed ID: 24578180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide.
    Kadish AS; Timmins P; Wang Y; Ho GY; Burk RD; Ketz J; He W; Romney SL; Johnson A; Angeletti R; Abadi M;
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):483-8. PubMed ID: 12010863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.
    Passmore JA; Milner M; Denny L; Sampson C; Marais DJ; Allan B; Gumbi PP; Hitzeroth II; Rybicki EP; Williamson AL
    Immunology; 2006 Dec; 119(4):507-14. PubMed ID: 17026720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ.
    Wang L; Li H; Liang F; Hong Y; Jiang S; Xiao L
    Med Oncol; 2014 Sep; 31(9):143. PubMed ID: 25106529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.
    Cheng WF; Lee CN; Su YN; Chang MC; Hsiao WC; Chen CA; Hsieh CY
    Immunology; 2005 May; 115(1):136-49. PubMed ID: 15819706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report].
    Pardo-Govea T; Callejas D; Núñez-Troconis J; Araujo M; Costa L; Pons H; Delgado M; Monsalve F
    Invest Clin; 2005 Mar; 46(1):5-13. PubMed ID: 15782532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of selected MHC class I and II molecule expression in the course of HPV positive CIN treatment with the use of human recombinant IFN-gamma.
    Sikorski M; Bobek M; Zrubek H; Marcinkiewicz J
    Acta Obstet Gynecol Scand; 2004 Mar; 83(3):299-307. PubMed ID: 14995928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.
    El-Sherif AM; Seth R; Tighe PJ; Jenkins D
    J Pathol; 2001 Sep; 195(2):179-85. PubMed ID: 11592096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine serum levels in patients with cervical intraepithelial neoplasia grade II-III treated with intralesional interferon-α 2b.
    Misson DR; Abdalla DR; Borges AM; Shimba DS; Adad SJ; Michelin MA; Murta EF
    Tumori; 2011; 97(5):578-84. PubMed ID: 22158487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
    BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.